One in four intermediate-sized (8-20 mm) pulmonary nodules were found to be malignant, based on results from a retrospective study of 377 patients seen in 18 community pulmonology...
Of the nearly 346,000 U.S. deaths caused by smoking-related cancers in 2011, about 48.5% were attributable to cigarette smoking, according to a research letter published online June 15 in JAMA...
SEATTLE – Adding radiotherapy to neoadjuvant chemotherapy does not improve long-term survival after pneumonectomy for non–small cell lung cancer, according to a Turkish <a...
GENEVA – Testing for mutations in the epidermal growth factor receptor gene has revolutionized treatment of advanced non–small cell lung cancer, but a significant proportion of patients with these...
Lung cancer patients who used statins in the year before being diagnosed with lung cancer had a 12% reduction in lung cancer-specific deaths (adjusted... More »
A new agent targeting tumors that develop resistance to EGFR tyrosine kinase inhibitors proved to be “highly active” in a phase I clinical trial i... More »
Rociletinib, a third-generation EGFR tyrosine kinase inhibitor that targets mutations causing treatment resistance, showed sustained activity against ... More »
GENEVA – Circulating tumor DNA currently has one role to play in routine management of lung cancer patients: To check at the time of diagnosis for a... More »
Poor baseline quality-of-life scores were not predictive of worse overall or recurrence-free survival, or of higher risk for adverse events following ... More »
CHICAGO – Nearly one-fourth of primary care providers were unaware of current lung cancer screening guidelines in a survey of 212 PC providers in North Carolina, a state with one of the nation’s...